Current best evidence on prescribed drugs

Drugdocs Logo

Current best evidence on prescribed drugs

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Tudorza Pressair

Chemical Nameaclidinium bromide inhalation powder
Dosage FormPowder (inhalation; 400 mcg)
Drug ClassAnticholinergics
SystemRespiratory
CompanyAstraZeneca
Approval Year2012

Indication

  • For the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD)
Last updated on 4/19/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Tudorza Pressair (aclidinium bromide inhalation powder) Prescribing Information.2019Circassia Pharmaceuticals Inc., Morrisville, NC
Document TitleYearSource
Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD) (review).2018Cochrane Database of Systematic Reviews
Efficacy and safety of aclidinium/formoterol versus tiotropium in COPD: results of an indirect treatment comparison.2016Advances in Therapy